Dec 1, 2023 at 6:50 PM#6
Saving this for reference. Top-tier content.
44 18VanRx_Mike, steve_okc, dave_SLC and 41 others
Reply Quote Save Share Report
Dec 1, 2023 at 7:07 PM#7
Slightly tangential to VERIFIED Q1 2026 approved but emily_PDX reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
42 13paul_denver, TinaHashiRN, robert_kc and 39 others
Reply Quote Save Share Report
Dec 1, 2023 at 7:24 PM#8
+1 to emily_PDX. Especially the point about "A few questions about your VERIFIED Q1 2..." — I have seen the same in my own experience with VERIFIED Q1 2026 approved.
15 8Dr.PulmRoch, maya_sedona, stefan_berlin and 12 others
Reply Quote Save Share Report
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDec 1, 2023 at 7:41 PM#9
GenomicsKate — that is really helpful context on VERIFIED Q1 2026 approved. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
26 0tommy_boulder, hyun_seoul, jim_asheville and 23 others
Reply Quote Save Share Report
Dec 1, 2023 at 7:58 PM#10
To answer lisa_labSD's question specifically:
From a clinical standpoint, VERIFIED Q1 2026 approved is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.
4 19kim_atl_prep, sarah_TO, wendy_avl and 1 other
Reply Quote Save Share Report